Israeli researchers are developing gene editing technology to fight the HIV virus

Israeli researchers have developed a new technology that engineer white blood cells against disease to fight HIV, the virus that causes AIDS. Scientists hope that the method used to edit CRISPR genes could lead to effective treatment for HIV and other diseases.

“We have developed an innovative treatment that can defeat the virus with a temporary injection that has the potential to dramatically improve the patient’s condition,” said Dr. Adi Barzel of Tel Aviv University, who co-led the research with PhD student Alessio Nehmad. .

The HIV virus attacks white blood cells in the body, weakening the immune system. There is no established cure for the disease, although today it used to be a chronic disease rather than the death penalty – if there are appropriate treatments.

Researchers at Tel Aviv University, along with other Israeli and U.S. scientists, say they have genetically engineered type B white blood cells to secrete antibodies to HIV. The technique was seen to be effective in animal models.

The new treatment injects genetically engineered type B white blood cells into a patient’s body to allow the immune system to secrete antibodies to fight the HIV virus.

Type B cells, a type of white blood cell, produce antibodies that fight viruses, bacteria, and other invaders. The Israeli team used CRISPR gene editing technology to incorporate antibodies encoded into B cells in the body.

Gene editing is a way to permanently change DNA to attack the root causes of a disease. CRISPR is a tool for cutting DNA at a specific location. It has been used in the laboratory for a long time and is being tested for other diseases.

Nehmad said in a note to the technology, “When CRISPR cuts the desired site in the B cell genome, it directs the entry of the desired gene – the gene that encodes the antibody against the HIV virus.”

Engineering When B cells encounter a virus in the body, the presence of the virus stimulates B cells and encourages them to divide.

“We’re using the same cause of the disease to address that,” Barzel said. “If the virus changes, B cells will also change accordingly to deal with it, so we have evolved in the body and created the first drug that can defeat the virus in the ‘arms race’.”

“We produced antibodies from the blood and made sure it was really effective in neutralizing the HIV virus on the lab plate,” Barzel said. “All the animal models who were treated responded and had large amounts of antibodies in their blood that they wanted.”

Researchers hope that in the coming years the technology will produce a drug against AIDS and other infectious diseases, including certain types of cancer.

The study was published in the journal Nature on Thursday.

It’s not (only) about you.

Supporting The Times of Israel is not a transaction for an online service, like a Netflix subscription. The ToI community is for people like you who care a common good: Ensuring that Israel’s balanced and responsible coverage remains free for millions of people around the world.

Of course, we’ll remove all ads from your page and give you access to amazing community-only content. But your help gives you something deeper than that: the pride of joining something really important.

Join the Times of Israel community Are you already a member of our community? Please sign in to stop watching this

You are a dedicated reader

That’s why we created the Times of Israel ten years ago – to give essential readers like you an essential reading of Israel and the Jewish world.

So now we have a request. Unlike other news outlets, we have not put up any tolls. But because of the costly journalism we do, we invite readers of The Times of Israel, who have become important, to help us support our work by joining. The Times of Israel Community.

For just $ 6 a month, you can help support our quality journalism while enjoying the Times of Israel WITHOUT ANNOUNCEMENTas well as access exclusive content Only available to Times of Israel community members.

Thank you,
David Horovitz, Founding Editor of The Times of Israel

Join our community Join our community Already a member? Please sign in to stop watching this

Leave a Comment